Volume 3, Issue 1, March 2022

View Volume 3, Issue 1, March 2022

Bullous Pemphigoid: Current and Emerging Therapies
Diluted and Hyperdiluted Calcium Hydroxyapatite For Skin Tightening
IL-17 Inhibitors and the Risk of Malignancy
Post-Inflammatory Hyperpigmentation: Pathogenesis, Diagnosis, and Treatment
An Overview of Rosacea
JAK-STAT Pathway Inhibitors: A New Jackpot for Dermatology

Published: 2022-03-01

Articles

Bullous Pemphigoid: Current and Emerging Therapies

Bahar Bahrani, MD

8–14
- PDF (en)
- PDF (fr)
Diluted and Hyperdiluted Calcium Hydroxyapatite For Skin Tightening

Malika Ladha, MD

16–19
- PDF (en)
- PDF (fr)
IL-17 Inhibitors and the Risk of Malignancy

Anthony Mak, MD

21–24
- PDF (en)
- PDF (fr)
Post-Inflammatory Hyperpigmentation: Pathogenesis, Diagnosis, and Treatment

Ben Kim, MD

26–29
- PDF (en)
- PDF (fr)
An Overview of Rosacea

Michael Sidiropoulos, MD, FRCPC

31–37
- PDF (en)
- PDF (fr)
JAK-STAT Pathway Inhibitors: A New Jackpot for Dermatology

Michal Bohdanowicz, MD, PhD, FRCPC

40–46
- PDF (en)
- PDF (fr)